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SUMMARY
Nowadays, drug-induced sleep endoscopy is widely recognised as a valid tool for diagnosis and treatment planning of obstructive sleep ap-
noea syndrome (OSAS), as it allows a direct visualisation of sites and patterns of collapse of the upper airways (UA). Various classifications 
have been proposed in the literature to describe the events observed during DISE, including the NOHL (Nasopharynx cavity and walls, 
Oropharynx, Hypopharynx, Larynx) classification (Vicini 2012). This study was aimed at assessing which anatomical structures, accord-
ing to the NOHL Classification, were most frequently involved in UA collapse in patients with moderate to severe OSAS, and evaluating 
treatment results with oral appliances (OA), in terms of AHI reduction. The study group consisted of 35 patients (29 M, 6 F, mean age 50.6, 
average BMI 26) with polysomnographic diagnosis of moderate to severe OSAS, subjected to DISE and classified according to the NOHL 
classification to identify the anatomical sites and patterns of UA collapse most frequently reported. Patients were subsequently addressed 
to mandibular advancing device (MAD) therapy and treatment results in terms of AHI reduction were evaluated. In the sample examined, 
the anatomical structures most frequently involved in the collapse of the UA were the nasopharynx cavity and walls and tongue base, with 
a correlation index of 0.35 (p < 0.04), while no significance was found for the retro-palatal area or larynx. Descriptive analysis revealed 
multilevel collapse in all patients, involving multiple anatomical structures in obstructive mechanics. In all patients, AHI reduction was 
observed after treatment with MAD (p < 0.00).
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RIASSUNTO 
La Drug-Induced Sleep Endoscopy (DISE) è ampiamente riconosciuta come un valido strumento per la diagnosi e la pianificazione del trat-
tamento della Sindrome delle Apnee Ostruttive (OSAS), in quanto consente una visualizzazione diretta dei siti e pattern di collasso delle Vie 
Aeree Superiori (VAS). In letteratura sono state proposte molteplici classificazioni per descrivere gli eventi osservati duranti la DISE, fra cui 
la NOHL (Nasopharynx cavity and walls, Oropharynx, Hypopharynx, Larynx) classification (Vicini 2012). Lo studio si prefigge gli obiettivi di 
identificare quali strutture anatomiche, definite secondo la classificazione NOHL, sono più rappresentate nel collasso delle VAS in pazienti con 
OSAS da moderato (15 ≤ AHI ≤ 30) a grave (AHI > 30), e valutare il risultato del trattamento con dispositivi orali (OA), in termini di riduzione 
dell’AHI. Il gruppo studio è composto da 35 pazienti (29 M, 6 F, età media 50.6, BMI medio 26) con diagnosi polisonnografica di OSAS da 
moderato a severo, sottoposti a DISE e classificati secondo la classificazione NOHL per individuare le sedi anatomiche e i pattern di collasso 
più frequentemente riportati. I pazienti sono stati successivamente indirizzati a terapia con Mandibular Advancing Devices (MAD), ed è stato 
valutato il risultato del trattamento in termini di riduzione dell’AHI. Nel campione esaminato, le strutture anatomiche più frequentemente 
coinvolte nel collasso delle VAS risultano essere il nasofaringe (N) e la base lingua (H), con indice di correlazione 0,35 (p < 0,04), mentre non 
è stata evidenziata significatività per l’area retropalatale (O) e la laringe (L). L’analisi descrittiva ha evidenziato inoltre un collasso multisede 
in tutti i pazienti, con coinvolgimento di più strutture nella meccanica ostruttiva. In tutti i pazienti è stata osservata una riduzione dell’AHI 
dopo terapia con MAD (p < 0,00), sebbene in alcuni casi non completamente risolutiva della patologia.
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Introduction
Nowadays, oral appliance therapy (OA) is considered to 
be effective for patients with primary snoring and mild to 
moderate OSAS, and could be an alternative for severe 
OSAS patients who refuse positive air pressure (PAP) 
therapies 1-3. In the literature, however, there is still con-
troversy about the selection criteria used to discriminate 
good responders to OA therapy from non-responders. His-
torically, patient selection has been based on AHI alone, 
although recent studies have focused on the use of drug 
induced sleep endoscopy (DISE) in diagnosis 4.
The technique of DISE, developed by Croft and Pringle 
in 1991 5, is aimed at exploring the upper airways during 
pharmacologically-induced sleep using a flexible fibro-
optic endoscope. DISE allows direct visualisation of ob-
struction sites and patterns of collapse in patients report-
ing snoring or OSAS, and can be useful in discriminating 
subjects who would benefit from surgical management 
from those who would not. During DISE it is also pos-
sible to mimic the effects of OA therapy by advancing 
the mandible with a gentle manoeuvre (pull up), in order 
to identify any improvements in UA patency or snoring. 
Patients showing a sufficient increase in UA dimension, 
as well as a reduction in snoring may be valid candidates 
for mandibular advancing devices (MAD) as a primary 
therapy or combined with surgery. 
In the literature, many authors have developed different 
grading systems to describe the anatomical structures in-
volved in UA collapse in OSAS patients 6 7, even though 
in this study we focused on the NOHL classification pub-
lished by Vicini in 2012 8. According to the NOHL clas-
sification, grading and pattern of obstruction can be eval-
uated at four different anatomic levels: N (Nasopharynx 
cavity and walls), O (Oropharynx – retro-palatal space), 
H (Hypopharynx - tongue base) and L (Larynx - epiglot-
tis). Grading of obstruction for nasopharynx cavities and 
pharyngeal walls can be classified as follows: 
• Grade 1: 0-25% collapse;
• Grade 2: 25-50% collapse;
• Grade 3: 50-75 % collapse;
• Grade 4: total collapse during Muller manoeuvre (100%).
The grading system described can be applied for both 
awake and sleep endoscopy; furthermore, it is possible to 
define the pattern of pharyngeal collapse (for O and H), 
as transversal (t), antero-posterior (ap) or concentric (c). 
The presence of any laryngeal (L) obstruction could be 
reported as p (positive) or n (negative), and if a consistent 
grade of palatine tonsillar hypertrophy is observed, it can 
be noted in the final report as TS (grade 3 or 4), for an 
instance N2O4cTS3H3apLn.
The aims of the present study are to define which anatomi-
cal structures of UA, defined according to the NOHL classi-
fication in DISE, are involved in the obstruction mechanics 
in moderate to severe OSA patients, and to evaluate treat-
ment outcomes with OA therapy in terms of AHI reduction.
Materials and methods
A retrospective study was conducted on 35 patients (29 
males, 6 females, mean age 56.09 ± 9.43 years, mean 
BMI 26.00 ± 3.52) who underwent polysomnography 
(PSG) and DISE to assess the presence of OSAS and who 
were subsequently addressed to MAD therapy.
The study group consisted of patients treated at the Oto-
rhinolaryngology Unit of the ‘G.B. Morgagni-Pierantoni 
Hospital’ (Forlì, Italy) from 2007 to 2017. Subjects in-
cluded in the study met the following criteria:
• age over 18 years;
• diagnosis of moderate (15 ≤ AHI ≤ 30) or severe OS-
AS (AHI > 30);
• poor adherence to C-PAP and eager to find a more 
comfortable alternative;
• patient suitable health conditions for the execution of 
DISE in order to clarify the diagnostic question;
• potentially eligible (after an accurate examination per-
formed by a dentist experienced in Dental Sleep Medi-
cine) to receive MAD treatment.
Patients came to the attention of the ENT specialist with a di-
agnosis of moderate or severe OSAS performed by standard 
full-night PSG (electron-encephalogram, oculography eye 
tracking, electromyogram, oronasal flow, pulse oximetry, 
respiratory effort, position, electrocardiogram, snoring).
The tracks obtained from the recordings were interpreted 
by a qualified sleep technician using the diagnostic crite-
ria of the 2007 International Classification of Sleep Disor-
ders and the definition of hypopnea was chosen according 
to the 2007 AASM scoring rules 9 (reduction of the flow ≥ 
50% from the baseline, duration at least 10 sec, accompa-
nied by ≥ 3% desaturation or an arousal).
The Epworth Sleepiness Scale Questionnaire (ESS, Johns 
1993) was also administered to patients to investigate the 
degree of daytime sleepiness prior to therapy.
In order to clarify the diagnostic question and select the 
most suitable therapeutic option, patients underwent DISE 
with sedation induced by propofol and TCI technique. 
Heart rate, frequency and saturation were monitored for 
the duration of the examination. Once adequate sedation 
was achieved, a flexible fibro-endoscope was introduced 
through one nostril and it was thus possible to observe sites 
and patterns of airway obstruction during induced sleep, 
classifying them according to the NOHL classification. 
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The NOHL classification was used to determine which UA 
anatomical structure was most frequently responsible for 
collapse in moderate or severe OSAS patients.
Finally, for all patients a manual mandibular advancement 
manoeuvre (pull up) was performed, in order to mimic the 
effect achieved with a MAD-type device. In our sample of 35 
patients, 23 showed an increase in UA volume and reduction 
in snoring, while the remaining 12 reported only a reduction 
in snoring. Since the pull up manoeuvre resulted in an im-
provement, in terms of increased UA patency and/or snoring 
in all the examined cases, all patients were considered suita-
ble candidates for MAD treatment. The OA consists of a cus-
tomisable device, removable and titled, made with precision 
silicone impressions (PVS) and a construction bite detected 
with George Gauge at 70% of the maximum protrusive. The 
same type of device was not used on all patients: the choice 
was personalised based on the patient’s characteristics.
Patients candidate for MAD therapy showed the follow-
ing characteristics:
• sufficient number of dental elements to support the 
device;
• absence of high dental mobility;
• good periodontal health;
• absence of DTMs or functional limitations.
The devices were delivered by dentists experienced in 
Dental Sleep Medicine and titrated, appointment by ap-
pointment, to optimise the therapeutic result based on da-
ta from PSG or cardio-respiratory monitoring with MAD 
in situ during follow-up.
The final PSG was performed at the end of the titration (on 
average, 6 months from the start of the therapy) with MAD 
in situ at optimal mandibular advancement with which it was 
possible to obtain resolution or reduction of symptoms.
For simplification, the AHI emerged from the initial PSG 
(pre-treatment), was compared with the AHI resulting from 
the final PSG with MAD in situ, in order to observe any 
improvements obtained with therapy. Treatment success 
was expressed as a reduction in AHI below 5 (resolution 
of OSA) or below 10 (very mild disease), or by a percent-
age reduction in AHI from baseline, which is considered 
to be clinically significant (typically 50% AHI reduction). 
Statistical analysis
Statistical analysis was conducted with the following ob-
jectives:
1. Define the association between the N, O, H, L scores 
and initial AHI shown by patients.
In this regard, the non-parametric correlation (Spearman 
rank correlation) was used, with the scores (N, O, H and 
L) expressed as non-continuous values. 
In order to define which anatomical site was potentially 
responsible for collapse described in the NOHL classi-
fication and which was more predictive of moderate to 
severe OSAS, the parameters (N, O, H and L) were ana-
lysed individually.
2. Descriptive analysis.
Since the sample size may be too small to be clinically 
appreciable with regards to the obstruction sites detected 
during DISE, many tables have been provided only for 
descriptive illustration without any supplementary infer-
ential analysis.
In particular, the relatively small number of the sample 
(35 subjects) made it necessary to neglect the role of the 
obstruction patterns (ap, t, c), for which only descriptive 
analyses were reported.
3. Difference between AHI before and after treatment.
The analysis of the difference between AHI pre- and post-
treatment value (used to evaluate the response to therapy) 
was performed with paired sample t-test.
Statistical analysis was conducted with R Statistical soft-
ware (R Core Team 2018), and the significance was set 
with a p value < 0.05.
Results
Predictiveness of the scores N, O, H, L with respect to 
initial AHI
Bivariate analysis showed a Spearman correlation index 
between score N and the initial AHI of 0.35 (p-value 
0.04). For the score O, the correlation index was instead 
0.30, (p-value 0.08), and the score H exhibited a Spear-
man correlation index of 0.35 (p-value 0.04). The results 
therefore showed a statistical significance for score N 
and H, both with a correlation index of 0.35 (p = 0.04), 
while the score O was weakly significant (p = 0.08). This 
implies that the nasopharynx cavity and walls (N-Nose) 
and the tongue base (H - Hypopharynx) were the most 
represented anatomic areas of collapse in this sample of 
patients with moderate/severe OSAS.
Descriptive analysis
Tables I-III display the average AHI by score N, O and H 
respectively as well as the percentages of patients for each 
obstruction site. No analyses were performed for the score 
L, because no patient reported obstructions at the level of 
the corresponding anatomical structure (epiglottis).
Difference between AHI before and after treatment with 
MAD
The results of the paired samples t-test showed a reduction 
of AHI after treatment with MAD compared to AHI pre-
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treatment (Fig. 1), with a significant difference (p-value = 
0.00). In our sample, 40% of patients showed a final AHI 
< 5, while 31.4% reported a post-treatment AHI between 
5 and 10. In the remaining 28.6% of patients, the AHI 
remained higher than 10, although there was a reduction 
of the initial value above 50%, indicating a good response 
to MAD therapy, as shown in Table IV.
Discussion
As widely described in the literature, DISE is an excellent 
method to define the anatomical sites and patterns of air-
way obstruction in patients with OSAS, in conditions that 
are similar to physiological sleep 4-7 10 11.
Among the numerous classifications that can be used 
in DISE, the NOHL classification proposed by Vicini (8) 
was chosen for the present study of the anatomical sites 
involved in the collapse of the UA. In a recent system-
atic review (Amos 2018) 12, it was found that there is no 
consensus in the literature regarding the use of a specific 
classification for the description of obstructive events ob-
Table I. Number of patients and initial average AHI for the score N (0-4).
Score N
0 1 2 3 4
Mean 
initial AHI




4 14 7 8 2
% 11,4% 40,0% 20,0% 22,9% 5,7%
Table II. Number of patients and initial average AHI for score O (1-3).
Score O
1 2 3
Mean initial AHI 30,0 37,7 46,8
Number of patients 5 23 7
% 14,3% 65,7% 20,0%
1c 2ap 2c 2t 3ap 3c
Mean initial AHI 30,0 52,5 35,2 29,4 34,7 48,9
Number of patients 5 5 13 5 1 6
% 14,3% 14,3% 37,1% 14,3% 2,9% 17,1%
Table III. Number of patients and initial average AHI for score H (1-4)..
Score H
1 2 3 4
Mean initial AHI 27,5 33,5 39,5 59,5
Number of 
patients
2 9 22 2
% 5,7% 25,7% 62,9% 5,7%
1t 2ap 2c 2t 3 3ap 3c 3t 4ap 4t
Mean initial AHI 27,5 35,5 31,8 24,7 77,0 32,4 42,5 38,1 87,0 32,0
Number of 
patients
2 6 2 1 1 6 6 9 1 1
% 5,7% 17,3% 5,7% 2,9% 2,9% 17,1% 17,1% 25,7% 2,9% 2,9%
Fig. 1. AHI values before and after MAD therapy.
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served in DISE, while the grading systems used most are 
the VOTE classification (38.6%), followed by the classifi-
cations of Pringle and Croft (15.9%), NOHL (9.1%) and 
Bachar (4.5%).
Identification of the anatomical sites responsible for the 
obstruction and their description turns out to be of funda-
mental importance to clarify the diagnostic question and 
select the most appropriate therapeutic option, especially 
when a surgical solution is required.
The information obtained by DISE is also valuable for 
selection of patients for MAD treatment 14-16: in particu-
lar, it was observed by Cistulli et al. that MADs showed 
greater efficacy when tongue base obstruction occurred,, 
while retro-palatal collapse was the main cause of lack of 
or incomplete response to therapy 16-18. 
However, in a study by Friedman et al. it was shown that, 
contrary to the hypothesis that tongue base obstruction would 
predict a good response to MAD therapy, OA achieved rea-
Table IV. Percentages of AHI reduction after MAD therapy compared to initial AHI.
Initial AHI Final AHI with MAD AHI reduction (%) Percentage of patients
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sonable response and cure rates in patients with primary 
retro-palatal, retro-lingual or epiglottis obstruction 19.
This study proposes assessment of sites most responsible 
for airway collapse in patients with moderate to severe 
OSAS, to define which structure (between N, O, H and 
L) described in the classification appears to be more rep-
resented and therefore associated with high values of AHI 
pre-treatment. The results of statistical analysis showed 
significance for scores N and H (both with correlation 
index 0.35 and p value 0.04), while score O exhibited a 
correlation index of 0.30, with p value 0.08 and therefore 
weakly significant. The L score was not analysed, since 
all the patients included in the sample scored 0.
N and H scores, emerged as significant from the analysis, 
refer to the anatomical regions of the nasopharynx cav-
ity and walls and the tongue base, which, according to 
the results of this study, would be more represented in 
the dynamics of obstruction in patients with moderate/se-
vere OSAS, while the role of site O (retro-palatal area) is 
weakly significant.
It has, however, been highlighted in several studies that 
most obstructions occur at the retro-palatal level. In par-
ticular, in the study by Vroegop in 2014 15, 81% of ob-
structions occurred at the retro-palatal level, followed by 
multilevel collapse (68.2%) with involvement of the pal-
ate and tongue base (25%). The high prevalence of retro-
palatal collapse was motivated, according to the authors, 
by the high frequency of snoring (due to vibration of soft 
palate tissues), as a nocturnal symptom commonly report-
ed by OSAS patients.
The results achieved in the present study differ from what 
has just been described probably due to the retrospective 
design and the small sample size (35 patients). Further-
more, different classification systems have been used in 
DISE by previous authors (VOTE classification), which 
can lead to a different description of the anatomical sites.
However, the descriptive analysis of the sample showed 
that airway collapse was always multilevel in patients 
with high AHI values, as observed in other studies 10 13. 
The involvement of several sites in the dynamics of ob-
struction poses the problem of the therapeutic choice, of-
ten requiring combined therapies (MAD + CPAP / MAD 
+ surgery).
Regarding the parameter L, no patient reported a collapse 
at the level of the epiglottis in the sample investigated. 
Before the advent of DISE, it was estimated that 12% of 
adult patients with OSAS showed epiglottis collapse 20. 
However, Torre et al. asserted in a systematic review that 
this aspect has long been underestimated and that, thanks 
to DISE, it will be possible to better clarify the role of the 
epiglottis in obstructive events of OSAS patients 21.
Unfortunately, it was not possible to define which ob-
struction pattern was more frequent for O and H, because 
the small number of subjects included in the sample made 
it possible to calculate only descriptive statistics.
In the literature, it has been found that high values of AHI 
and BMI are more frequently associated with complete 
retro-palatal collapse with concentric pattern, as well as a 
greater probability of complete collapse at the hypophar-
ynx (including epiglottis), with lateral pattern 13, motivated 
both by the accumulation of fat at the side of the pharynx.
In subjects treated with MAD, an important reduction of 
the AHI with respect to the initial value was observed in 
all patients, underlining the confirmed efficacy of MADs 
in OSAS treatment. In particular, in the sample of patients 
examined, obstruction was more frequently observed at 
tongue base level (H), which could motivate the success 
of MAD therapy. Furthermore, it is interesting to observe 
how, since the study group consists of moderate/severe 
OSAS patients, MAD therapy often fails to completely 
resolve the disease (AHI is often maintained > 5). Patients 
who did not completely respond to MAD therapy, apart 
from having a very high initial AHI value, reported high 
scores for the N and/or the O parameters, highlighting 
once again a multilevel obstruction dynamic that often 
requires a multidisciplinary approach and evaluation for 
possible surgery addressed to the sites involved in UA col-
lapse (nasal cavity and walls or palate). It should also be 
specified that for moderate or severe OSAS patients, the 
gold standard therapeutic option always remains CPAP. 
However, the poor adherence to this solution may lead 
adoption of MAD therapy alone or combined with sur-
gery. Finally, it is noted that patients with moderate or 
severe OSAS often show comorbidities associated with 
OSAS, which may affect the final result of the therapy.
The present study has numerous limitations, starting from 
its retrospective design and relatively small number of 
patients involved. It would be interesting, however, to ex-
tend the sample and repeat the DISE with MAD in situ to 
observe the behaviour of the airway in response to man-
dibular advancement, in order to provide more precise re-
sults about the predictability of treatment with OA.
Conclusions
Within the limits of this study, it is possible to draw the 
following conclusions:
• DISE appears to be the gold standard exam for diagno-
sis of obstruction sites in patients with OSAS;
• among the structures described in the NOHL clas-
sification, the nasopharynx cavity and walls (N) and 
tongue base (H) were the obstruction sites most fre-
NOHL classification for OSAS diagnosis in DISE and MAD treatment
7
Address for correspondence: Valentina Colabianchi, Department of Orthodontics, University of Ferrara, via Montebello 31, 44100 Ferra-
ra, Italy. E-mail: valentin.colabianchi@gmail.com
Received: July 26, 2018 - Accepted: November 30, 2018
How to cite this article: Vicini C, Colabianchi V, Marrano GG, et al. Description of the relationship between NOHL classification in 
drug-induced sleep endoscopy and initial AHI in patients with moderate to severe OSAS, and evaluation of the results obtained with oral 
appliance therapy. Acta Otorhinolaryngol Ital Epub 2019 Sep 30. https://doi.org/10.14639/0392-100X-2290
quently reported in this sample of patients with mod-
erate to severe OSAS;
• although MAD therapy is not the gold standard, it is 
effective in reducing initial AHI in patients with mod-
erate to severe OSAS and contributes to a reduction in 
symptoms;
• the multilevel nature of the collapse observed in pa-
tients with moderate or severe OSAS often requires 
combined treatments (e.g. MAD + CPAP, MAD + 
surgery), emphasising the need for a multidisciplinary 
approach.
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